|
|
|
| Trend in burden of rheumatoid arthritis in China from 1990 to 2021 |
| WEN Jiaxin, JIANG Junpeng, FENG Min, SHEN Xiaochen, LI Xiaoyin
|
| Gusu District Center for Disease Control and Prevention, Suzhou, Jiangsu 215000, China |
|
|
|
|
Abstract Objective To analyze the trend in burden of rheumatoid arthritis (RA) in China from 1990 to 2021, so as to provide insights into reducing the RA burden in China. Methods Data of Global Burden of Disease Study 2021 were collected, and the incidence, mortality and disability-adjusted life years (DALY) of RA in China from 1990 to 2021 were analyzed and compared with global and different Socio-demographic Index (SDI) regions. The trend in burden of RA was analyzed using average annual percent change (AAPC). Results The crude incidence rates of RA in China increased from 10.87/105 in 1990 to 17.38/105 in 2021, the crude mortality rates increased from 0.41/105 to 0.72/105, and the crude DALY rates increased from 34.26/105 to 58.61/105, with the increases of 59.98%, 77.95% and 71.06%, respectively. From 1990 to 2021, the standardized incidence rates of RA in China showed an increasing trend (AAPC=0.545%, P<0.05), the standardized mortality rates showed a decreasing trend (AAPC=-0.783%, P<0.05), and the standardized DALY rates showed no significant trend (AAPC=-0.017%, P>0.05). In 2021, the standardized incidence rate, standardized mortality rate and standardized DALY rate of RA were higher in females than in males; from 1990 to 2021, the standardized DALY rates of RA showed a decreasing trend in females (AAPC=-0.200%, P<0.05) and an increasing trend in males (AAPC=0.316%, P<0.05). The crude incidence rates of RA first increased and then decreased with age in 2021, reaching the highest in the age group of 75-<80 years at 34.36/105. Both the crude mortality rates and the crude DALY rates increased with age, reaching the highest in the age group of 95 years and older at 26.72/105 and 285.67/105, respectively. The standardized incidence rates and standardized DALY rates of RA in China in 2021 were lower than those in high SDI regions, while the standardized mortality rate was lower than that in medium-low SDI regions. Conclusions The burden of RA in China from 1990 to 2021 showed an upward trend, and was at a high level compared to different SDI regions. Higher disease burden of RA was seen in females and the elderly.
|
|
Received: 16 August 2024
Revised: 05 October 2024
Published: 14 January 2025
|
|
|
|
|
|
[1] 中华医学会风湿病学分会.2018中国类风湿关节炎诊疗指南[J].中华内科杂志,2018,57(4):242-251.
Chinese Rheumatology Association.2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis[J].Chin J Intern Med,2018,57(4):242-251.(in Chinese)
[2] 孙学菁,王丽芹,高兆虹,等.类风湿关节炎患者运动自我效能在社会支持与运动恐惧间的中介效应分析[J].预防医学,2024,36(5):378-382.
SUN X J,WANG L Q,GAO Z H,et al.Mediating effect of self-efficacy for exercise on social support and kinesiophobia in patients with rheumatoid arthritis[J].China Prev Med J,2024,36(5):378-382.(in Chinese)
[3] GBD 2021 Rheumatoid Arthritis Collaborators.Global,regional,and national burden of rheumatoid arthritis,1990-2020,and projections to 2050:a systematic analysis of the Global Burden of Disease Study 2021BD 2021 Rheumatoid Arthritis Collaborators.Global,regional,and national burden of rheumatoid arthritis,1990-2020,and projections to 2050:a systematic analysis of the Global Burden of Disease Study 2021[J].Lancet Rheumatol,2023,5(10):594-610.
[4] TIAN X P,LI M T,ZENG X F.The current status and challenges in the diagnosis and treatment of rheumatoid arthritis in China:an annual report of 2019[J].Rheumatol Immunol Res,2021,2(1):49-56.
[5] XIE W H,YANG X L,ZHANG Z L.The plight and light of treating rheumatoid arthritis in China[J].Lancet Rheumatol,2019,1(2):81-82.
[6] HU H,LUAN L,YANG K Q,et al.Burden of rheumatoid arthritis from a societal perspective:a prevalence-based study on cost of this illness for patients in China[J].Int J Rheum Dis,2018,21(8):1572-1580.
[7] GBD 2021 Diseases and Injuries Collaborators.Global incidence,prevalence,years lived with disability(YLDs),disability-adjusted life-years(DALYs),and healthy life expectancy(HALE)for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2133-2161.
[8] 国家统计局.中国统计年鉴[EB/OL].[2024-10-05].https://www.stats.gov.cn/sj/ndsj.
[9] 甘雨舟,李茹.甲氨蝶呤治疗类风湿关节炎的跌宕历程[J].中华风湿病学杂志,2018,22(1):34-35.
GAN Y Z,LI R.The turbulent journey of methotrexate in the treatment of rheumatoid arthritis[J].Chin J Rheumatol,2018,22(1):34-35.(in Chinese)
[10] 赵艳荣,邱银伟,杨清,等.浙江省社区健康管理老年人慢性病患病现况研究[J].预防医学,2017,29(3):217-220,225.
ZHAO Y R,QIU Y W,YANG Q,et al.A study on the prevalence of chronic diseases and risk factors control among the elderly of community health management in Zhejiang Province[J].China Prev Med J,2017,29(3):217-220,225.(in Chinese)
[11] XING E,BILLI A C,GUDJONSSON J E.Sex bias and autoimmune diseases[J].J Invest Dermatol,2022,142(3 Pt B):857-866.
[12] FINCKH A,GILBERT B,HODKINSON B,et al.Global epidemiology of rheumatoid arthritis[J].Nat Rev Rheumatol,2022,18(10):591-602.
[13] ISLANDER U,JOCHEMS C,LAGERQUIST M K,et al.Estrogens in rheumatoid arthritis:the immune system and bone[J].Mol Cell Endocrinol,2011,335(1):14-29.
[14] HASSEN N,LACAILLE D,XU A,et al.National burden of rheumatoid arthritis in Canada,1990-2019:findings from the Global Burden of Disease Study 2019-a GBD collaborator-led study[J/OL].RMD Open,2024,10(1)[2024-10-05].http://doi.org/10.1136/rmdopen-2023-003533.
[15] MOUSAVI S E,NEJADGHADERI S A,KHABBAZI A,et al.The burden of rheumatoid arthritis in the Middle East and North Africa region,1990-2019[J/OL].Sci Rep,2022,12[2024-10-05].https://doi.org/10.1038/s41598-022-22310-0.
[16] 林进,徐丹怡.重视老年类风湿关节炎诊治[J].中华风湿病学杂志,2017,21(12):859-861.
LIN J,XU D Y.Emphasis on the diagnosis and treatment of rheumatoid arthritis in the elderly[J].Chin J Rheumatol,2017,21(12):859-861.(in Chinese)
[17] 李煜楠,徐鹏程,贾俊亚,等.体质指数与25种自身免疫性疾病的孟德尔随机化研究[J].预防医学,2024,36(5):388-392.
LI Y N,XU P C,JIA J Y,et al.Mendelian randomization study on body mass index and 25 types of autoimmune diseases[J].China Prev Med J,2024,36(5):388-392.(in Chinese)
[18] YAMAMOTO S S,YACYSHYN E,JHANGRI G S,et al.Household air pollution and arthritis in low-and middle-income countries:cross-sectional evidence from the World Health Organization's study on Global Ageing and Adult Health[J/OL].PLoS One,2019,14(12)[2024-10-05].http://doi.org/10.1371/journal.pone.0226738.
[19] 赵晴晴,丛舒,樊静,等.2019—2020年中国40岁及以上人群吸烟状况分析[J].中华流行病学杂志,2023,44(5):735-742.
ZHAO Q Q,CONG S,FAN J,et al.Prevalence of smoking in adults aged 40 years and above in China,2019-2020[J].Chin J Epidemiol,2023,44(5):735-742.(in Chinese)
[20] World Health Organization.Air pollution in China[EB/OL].[2024-10-05].https://www.who.int/china/zh/health-topics/air-pollution. |
|
|
|
